Company Snapshot: CAH  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility

    DUBLIN, Ohio, Dec. 7 /PRNewswire-FirstCall/ -- Cardinal Health today
announced that the U.S. Drug Enforcement Administration (DEA) has suspended
its license to distribute controlled substances from its Lakeland, Fla.
distribution center, effective Dec. 10.

    To ensure continuity of service, the company is making arrangements to
distribute controlled substances to affected customers from other
facilities within its network of 25 pharmaceutical distribution centers.

    Chairman and Chief Executive Officer R. Kerry Clark said: "Anything
less than best-in-class controls for the pharmaceutical supply chain is
unacceptable. We will do what it takes to address this execution issue with
changes to our processes and systems. The security of the pharmaceutical
supply chain is core to our business and we are committed to the highest
standards as we work with the DEA to resolve this matter."

    Cardinal Health has been reviewing its controlled substance procedures,
and as a result is implementing near- and long-term enhancements that
further guard against distribution to pharmacies engaged in diversion.

    About Cardinal Health

    Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an
$87 billion, global company serving the health care industry with products
and services that help hospitals, physician offices and pharmacies reduce
costs, improve safety, productivity and profitability, and deliver better
care to patients. With a focus on making supply chains more efficient,
reducing hospital-acquired infections and breaking the cycle of harmful
medication errors, Cardinal Health develops market leading technologies,
including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems,
MedMined(TM) infection surveillance services and the CareFusion(TM) patient
identification system. The company also manufactures medical and surgical
products and is one of the largest distributors of pharmaceuticals and
medical supplies worldwide. Ranked No. 19 on the Fortune 500 and No. 1 in
its sector on Fortune's ranking of Most Admired firms, Cardinal Health
employs more than 40,000 people on five continents. More information about
the company may be found at http://www.cardinalhealth.com.



SOURCE Cardinal Health, Inc.




Back to Topback to top

Related links:
  • http://www.cardinalhealth.com
    CONTACT:
    Media, Jim Mazzola, +1-614-757-3690,
    jim.mazzola@cardinal.com, or Investors, Bob Reflogal,
    +1-614-757-7542, bob.reflogal@cardinal.com, both of Cardinal
    Health, Inc.